Evidence map›Paper›PMID 30787056›Full record

ArticleDiabetes care2019

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes.

Irl B Hirsch, Jennifer L Sherr, Korey K Hood

Abstract readComment
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. To What Extent Is HbJournal of clinical medicine · 2024
    Article
  11. Article
  12. Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Review
  13. Article
  14. Digital Diabetes Management: A Literature Review of Smart Insulin Pens.Journal of diabetes science and technology · 2022
    Review
  15. Article
  16. Multimorbidity Among Adult Outpatients With Type 1 Diabetes in Germany.Journal of diabetes science and technology · 2022
    Article
  17. Article
  18. Feasibility of Implementing a Pediatric Diabetes Clinic via Telehealth.Diabetes spectrum : a publication of the American Diabetes Association · 2021
    Article
  19. Time in Range as a Research Outcome Measure.Diabetes spectrum : a publication of the American Diabetes Association · 2021
    Article
  20. Clinical Application of Time in Range and Other Metrics.Diabetes spectrum : a publication of the American Diabetes Association · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Irl B HirschDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA.ORCID 0000-0003-1675-8417
Jennifer L SherrDepartment of Pediatric Endocrinology, Yale School of Medicine, New Haven, CT.ORCID 0000-0001-9301-3043
Korey K HoodDepartment of Pediatrics, Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA kkhood@stanford.edu.ORCID 0000-0001-5730-7749

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusData CollectionHumansOutcome Assessment, Health CareTime

Identifiers

PMID30787056
PMCPMC6973546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.